Health claim evaluation on fructan mixture and normal defecation published by EFSA
Aug 17, 2021
On August 12, EFSA published an evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006: Frutalose®, a mixture of fructans obtained from enzymatic hydrolysis of chicory inulin, and normal defecation.
One human intervention study showed an effect of Frutalose® on the maintenance of normal defecation by increasing stool frequency and improving stool consistency (softer stools) when consumed daily at a dose of 15 g for 8 weeks. The results have not been replicated in other studies. There is a plausible mechanism by which Frutalose® could exert the claimed effect. The Panel concludes that the evidence provided is insufficient to establish a cause and effect relationship between the consumption of Frutalose® and maintenance of normal defecation under the proposed conditions of use.
For further information (in English), click on the Link